Long-Term Impact of Direct-Acting Antivirals on Liver Fibrosis and Survival in HCV-Infected Liver Transplant Recipients

Long-Term Impact of Direct-Acting Antivirals on Liver Fibrosis and Survival in HCV-Infected Liver Transplant Recipients

(1) Background: Little is known about the long-term impact of sustained virological response (SVR) on fibrosis progression and patient survival in liver transplantation (LT) recipients treated with direct-acting antivirals (DAAs). We investigated liver fibrosis evolution and patient survival in hepa...

Full description

Bibliographic Details
Main Authors: Martina Gambato, Chiara Manuli, Erica N. Lynch, Sara Battistella, Giacomo Germani, Marco Senzolo, Alberto Zanetto, Alberto Ferrarese, Alessandro Vitale, Enrico Gringeri, Umberto Cillo, Patrizia Burra, Francesco Paolo Russo
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Viruses
Subjects:
hepatitis C virus
DAAs
liver transplantation
Online Access:https://www.mdpi.com/1999-4915/15/8/1702

Internet

https://www.mdpi.com/1999-4915/15/8/1702

Similar Items